Annual Cash & Cash Equivalents
$120.57 M
-$119.98 M-49.88%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual cash & cash equivalents is $120.57 million, with the most recent change of -$119.98 million (-49.88%) on December 31, 2023.
- During the last 3 years, MRNS annual cash & cash equivalents has fallen by -$17.94 million (-12.95%).
- MRNS annual cash & cash equivalents is now -49.88% below its all-time high of $240.55 million, reached on December 31, 2022.
Performance
MRNS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$42.18 M
-$22.49 M-34.78%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly cash and cash equivalents is $42.18 million, with the most recent change of -$22.49 million (-34.78%) on September 30, 2024.
- Over the past year, MRNS quarterly cash and cash equivalents has stayed the same.
- MRNS quarterly cash and cash equivalents is now -82.46% below its all-time high of $240.55 million, reached on December 31, 2022.
Performance
MRNS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MRNS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.9% | 0.0% |
| 3 y3 years | -12.9% | -82.5% |
| 5 y5 years | +78.0% | -82.5% |
MRNS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.9% | at low | -82.5% | at low |
| 5 y | 5-year | -49.9% | +32.6% | -82.5% | at low |
| alltime | all time | -49.9% | +1296.5% | -82.5% | +401.3% |
Marinus Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $42.18 M(-34.8%) |
| Jun 2024 | - | $64.68 M(-38.0%) |
| Mar 2024 | - | $104.25 M(-13.5%) |
| Dec 2023 | $120.57 M(-49.9%) | $120.57 M(-14.1%) |
| Sep 2023 | - | $140.44 M(+9.9%) |
| Jun 2023 | - | $127.79 M(-13.0%) |
| Mar 2023 | - | $146.90 M(-38.9%) |
| Dec 2022 | $240.55 M(+95.7%) | $240.55 M(+43.0%) |
| Sep 2022 | - | $168.25 M(+82.2%) |
| Jun 2022 | - | $92.33 M(-26.9%) |
| Mar 2022 | - | $126.32 M(+2.8%) |
| Dec 2021 | $122.93 M(-11.2%) | $122.93 M(-15.3%) |
| Sep 2021 | - | $145.10 M(+29.0%) |
| Jun 2021 | - | $112.49 M(-8.9%) |
| Mar 2021 | - | $123.47 M(-10.9%) |
| Dec 2020 | $138.51 M(+52.3%) | $138.51 M(+58.6%) |
| Sep 2020 | - | $87.34 M(-11.7%) |
| Jun 2020 | - | $98.93 M(+40.7%) |
| Mar 2020 | - | $70.33 M(-22.7%) |
| Dec 2019 | $90.94 M | $90.94 M(+144.7%) |
| Sep 2019 | - | $37.16 M(-24.8%) |
| Jun 2019 | - | $49.44 M(-18.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $60.85 M(-10.2%) |
| Dec 2018 | $67.73 M(+102.0%) | $67.73 M(+244.5%) |
| Sep 2018 | - | $19.66 M(-8.4%) |
| Jun 2018 | - | $21.47 M(-21.0%) |
| Mar 2018 | - | $27.18 M(-18.9%) |
| Dec 2017 | $33.53 M(+28.1%) | $33.53 M(-10.7%) |
| Sep 2017 | - | $37.53 M(+92.2%) |
| Jun 2017 | - | $19.53 M(-13.5%) |
| Mar 2017 | - | $22.58 M(-13.8%) |
| Dec 2016 | $26.18 M(-49.4%) | $26.18 M(-20.4%) |
| Sep 2016 | - | $32.90 M(-15.9%) |
| Jun 2016 | - | $39.10 M(-16.3%) |
| Mar 2016 | - | $46.73 M(-9.7%) |
| Dec 2015 | $51.72 M(+4.0%) | $51.72 M(+84.5%) |
| Sep 2015 | - | $28.03 M(-28.0%) |
| Jun 2015 | - | $38.93 M(-12.5%) |
| Mar 2015 | - | $44.48 M(-10.5%) |
| Dec 2014 | $49.72 M(+395.4%) | $49.72 M(+5.6%) |
| Sep 2014 | - | $47.11 M(+459.7%) |
| Jun 2014 | - | $8.42 M(-4.7%) |
| Mar 2014 | - | $8.83 M(-12.0%) |
| Dec 2013 | $10.04 M(+16.3%) | $10.04 M |
| Dec 2012 | $8.63 M | - |
FAQ
- What is Marinus Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Marinus Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Marinus Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of MRNS is $120.57 M
What is the all time high annual cash & cash equivalents for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual cash & cash equivalents is $240.55 M
What is Marinus Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, MRNS annual cash & cash equivalents has changed by -$119.98 M (-49.88%)
What is Marinus Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MRNS is $42.18 M
What is the all time high quarterly cash and cash equivalents for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly cash and cash equivalents is $240.55 M
What is Marinus Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, MRNS quarterly cash and cash equivalents has changed by $0.00 (0.00%)